Synthetically lethal nanoparticles for treatment of endometrial cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetically lethal nanoparticles for treatment of endometrial cancer
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 13, Issue 1, Pages 72-81
Publisher
Springer Nature
Online
2017-12-01
DOI
10.1038/s41565-017-0009-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Mechanisms for the Antifibrotic Action of Nintedanib
- (2016) Sunad Rangarajan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Andreas du Bois et al. LANCET ONCOLOGY
- Enhanced cellular uptake of nanoparticles by increasing the hydrophobicity of poly(lactic acid) through copolymerization with cell-membrane-lipid components
- (2015) Mariam Samadi Moghaddam et al. CHEMICAL COMMUNICATIONS
- A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2015) David Bender et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
- (2014) Don S. Dizon et al. GYNECOLOGIC ONCOLOGY
- Vitamin E-based nanomedicines for anti-cancer drug delivery
- (2014) Nicolas Duhem et al. JOURNAL OF CONTROLLED RELEASE
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Applying Synthetic Lethality for the Selective Targeting of Cancer
- (2014) Donal P. McLornan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Formulation and Optimization of Nonionic Surfactants Emulsified Nimesulide-Loaded PLGA-Based Nanoparticles by Design of Experiments
- (2013) Ceyda Tuba Sengel Turk et al. AAPS PHARMSCITECH
- Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance
- (2013) Huijun Zhu et al. BIOMATERIALS
- The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
- (2013) Pavla Brachova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel
- (2013) Guoying Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53
- (2012) Xiangbing Meng et al. GYNECOLOGIC ONCOLOGY
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
- (2011) Rassoul Dinarvand et al. International Journal of Nanomedicine
- Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
- (2011) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells
- (2011) Daniela Guarnieri et al. JOURNAL OF NANOPARTICLE RESEARCH
- Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistance
- (2011) Qing-feng Xiang et al. CELLULAR ONCOLOGY
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
- (2010) Sarbari Acharya et al. ADVANCED DRUG DELIVERY REVIEWS
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review
- (2009) David M. Boruta et al. GYNECOLOGIC ONCOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Novel molecular profiles of endometrial cancer—new light through old windows
- (2007) A. Doll et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now